chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving first dose, I had brain fog, visual disturbance and fatigue for several days.  The same thing happened with the second vaccine, but much worse.  The visual disturbance was worse, and has progressively gotten worse.  Picture looking through a gray veil covered with glitter and smears.  After receiving both vaccines, I also contracted COVID anyway.   I believe my vision failure is due to the vaccines, as the onset coincides with the injections.  Multiple eye exams have revealed nothing physically wrong with my eyes, and I'm awaiting an exam with a neurologist.
No adverse event-patient received a full strength (0.5ml) 2nd booster of Moderna covid-19 vaccine instead of 0.25ml
Patient stated she had a red spot on her arm that was hot to the touch and lasted several days. She recovered a few days later. Itching occured at injection site but no where else on body.
Information has been received from a consumer concerning her approximately 15 weeks daughter with craniosynostosis and no drug reactions or allergies who on 04-JAN-2005 was vaccinated with the first dose of COMVAX (lot# 649555/0493P). On 03-MAR-2005, the patient was vaccinated with the second dose of COMVAX (lot# 652710/0695R). On 10-NOV-2005 was vaccinated with the third dose of COMVAX (lot# 649288/0411P) and the first dose of MMR II (HSA, lot# 649755/0380R). On 02-DEC-2009, the patient was vaccinated with the second dose of MMR II (HSA, lot# 649755/0380R). On an unspecified date, the patient was vaccinated with a dose of VARIVAX (lot#646816/0631R). There was no other concomitant medication. On an unspecified date "around March 2005", the patient's mother started to notice that her daughter had swollen feet and then blisters that were fluid filled sacks and this lasted for about 2 weeks and then cleared up. The patient's mother also reported that her daughter's allergic reaction looked like Henoch-Schonlein Purpura disease but it was not conclusive. Unspecified medical attention was sought. Blood work was performed with no result reported. The patient's mother requested some samples for her daughter. It was reported that the adverse event improved after stopping the therapy. The patient recovered in January 2010. Upon internal review, the Henoch-Schonlein Purpura was considered to be an other important medical event. Additional information has been requested.
Patient had fever of 101.7 starting the night of receiving the shot and lasting for 2 days - no other problem or symptoms.
Patient was given a Novavax vaccine shot but had already gotten 2 Janssen Covid vaccines. This was given before Novavax was approved as a booster on 10/19/22
This spontaneous report was received from a female patient of unknown age, regarding herself. Patient's concurrent conditions included drug reactions/allergies to LODINE and morphine. Other relevant medical history was reported as none. Approximately on an unknown date in 2011 (reported as 4 years ago) the patient was vaccinated with ZOSTAVAX, (1 single shot) (lot number and route unspecified). Concomitant therapies included tetanus toxoid vaccine, hepatitis b vaccine (manufacturer unknown) and multiple unspecified medications. On 08-NOV-2014 the patient developed pain that radiated from her tooth area to her eye. The patient went to emergency room where she was diagnosed with shingles after receiving ZOSTAVAX. The patient sought medical attention by speaking with physician. X-ray and other unspecified tests were conducted of which results were unknown. The patient was treated with VALTREX. The patient stated that shingles were around her eye,forehead, nose, cheek and temple. The patient stated that she could not take care of herself  for 2 months and during that time she slept for 20 hours a day. The outcome of the events was reported as not recovered/not resolved. The causality of the events with ZOSTAVAX was not reported. Additional information has been requested.
Severe debilitating  headache left side Fatigue  Chills Fever Body aches Lower back pain Nausea Vomiting Internal pains/Organs Dizziness Swelling and redness at injection site Weakness Swelling/redness around eyes
Following first dose, only experienced fatigue and slight headache for one and a half days. Following second dose I experienced painful injection site for 2 days along with fatigue and generalized "out of sorts" for 2 days then felt quite well enough to resume normal activities and even took a 40 minute walk. That night (3/20) I had serious night sweats (fever?) and the following morning my arm at the injection site was hot and swollen and splotchy red,  my face was swollen on the left side (side of injection, and my left temple was extremely painful to touch. I had a slight fever (100.5) and experienced a period of horrible chills.  Later in the day my left eye became swollen and the area above my ear and eye and about one third of my forehead were bright angry red although the sensitivity of the temple had lessened. It was a Sunday and there was no walk-in clinic available so I contacted a Zoom style doctor through insurance.  She advised she believed it to be an allergic reaction and that I should go to an emergency room. I wasn't experiencing any breathing issues and was no longer feeling feverish and chills so decided to wait and see what the morning would bring. Monday am the redness and swelling had spread to the right side of my face and the areas behind both ears and down my neck so decided I should be seen. I had already come to believe these were swollen lymph nodes and the Physicians Assistant I was able to see diagnosed as lymphadenopathy.  The swellings and pain  receded over the next few days.  I still (4/1) have some stiffness in my left jaw and slight redness around my right eye above my ear.
Shingles; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 77-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced shingles after receiving 1st dose of Shingrix. Till the time of reporting, the patient had not received the 2nd dose of Shingrix and asked if the 2nd dose could be received after the shingles goes away.
itching inside arms & neck & ankles & underside of legs;areas became swollen & hot;rash like tiny h20 blisters;sx lasted about 3wk, took DPH & hydrocortisone cream;
Patient was administered her 2nd Moderna COVID-19 vaccine dose at wrong interval and one week too early.  Moderna #2 was administered at 21-day interval instead of the correct interval of 28 days.    Pt presented to our clinic exactly 1 week early for her 2nd dose of Moderna, this was not noticed, and vaccinator proceeded with administering the 2nd dose of Moderna.     Patient received her first dose of Moderna at our vaccine clinic on May 22, 2021; corresponding Lot # P005C21A, expiration 10/22/21.  Paperwork that patient brought to the vaccinator contained the date of 6/19/21 as the correct date patient was due to return for her 2nd dose.   I have made a call to the patient to inform her and have not reached her yet.  Patient to be informed of error and that a VAERS report was filed for this incident.
Tdap given 8/28/06 in right deltoid, pt began with pain later same day from right neck down right arm and hand. No redness, warmth or induration at injection site but marked tenderness from upper shoulder to right hand, even to light touch. 8/29/06.
Fever; Chills; Headache; Nauseous; Lot of vomiting; Migraine; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous) and VOMITING (Lot of vomiting) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergic asthma.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous), VOMITING (Lot of vomiting) and MIGRAINE (Migraine). The patient was treated with DIMENHYDRINATE (DRAMAMINE) for Migraine, at an unspecified dose and frequency. On 27-Feb-2021, PYREXIA (Fever), CHILLS (Chills), HEADACHE (Headache), NAUSEA (Nauseous), VOMITING (Lot of vomiting) and MIGRAINE (Migraine) had resolved.            Concomitant medications included Vitamins  Action taken with mRNA-1273 in response to the events was not applicable.
Started developing a rash on her leg the evening of 7/31/17, then by 8/1/17 had widespread urticaria - was seen by myself to confirm diagnosis.
pt recv vax & 25JUL96 pt @ day care-staff observed pt to have 2 episodes where pt abruptly stopped playing, stared off into space w/leg twitching for 30-40 sec;this was followed by 30-60min of lethargy/sleeping;
Diagnosed with covid-19; admitted to inpatient hospital; supportive care needed (oxygen, steroids, remdesivir).
Child received Hep A #1, MMR #2 and Varivax #2 3/6/08.  Within 4-5 minutes after vaccines child had small hives on face, legs and back.  No shortness of breath, no wheezing.  Benadryl given after 15-20 min.  Child feeling better, hives decreased, itching decreased, no shortness of breath.
From initial information received on 8/3/04 from a health care professional regarding an adverse event occurring in the USA, it was reported that a female patient (age and date of birth not reported) received a dose of IMOVAX RABIES as part of a pre-exposure series on an unspecified date. The lot number, route and site of administration were not reported. An unspecified amount of time later, the patient developed eyelid swelling and sores on her nose that would not resolve. It was not reported whether the patient recovered from these events. The reporter had minimal information regarding this case.
Hot flashes Red face Feeling like she was going to pass out or throw up if she didn't lie down Fatigue prodome Fast HR feeling episodes
Feeling like a mini stroke; Numbness extended from mouth and teeth down to legs; Teeth numbness; This case was reported by a physician via sales rep and described the occurrence of feeling abnormal in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a day after receiving Shingrix, the patient experienced feeling abnormal, numbness localized and numbness oral. On an unknown date, the outcome of the feeling abnormal, numbness localized and numbness oral were unknown.   It was unknown if the reporter considered the feeling abnormal, numbness localized and numbness oral to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and later that day the left side of the patient's body went numb described as feeling like a mini stroke. The numbness extended from mouth and teeth down to legs. The reporter consented to follow up.
Subject in pneumococcal vaccine trial with severe COPD was hospitalized with Pneumonia. Vaccination took place on 9.22.2008. According to the physician the relationship to study is none. We would be happy to fax the Study's SAE report.
Fatigue, tingling in lips and face   Narrative: Employee reported localized swelling, chills with diaphoresis, extreme fatigue & tingling in lips face lasting several hours. Pt recovered spontaneously without further intervention.
Extremely ill; Fever; Extreme fatigue; Pain; Muscle aches; Headache; Fuzzy head and foggy thinking; feeling absolutely miserable beginning 24 hours after 1st dose; Could not work; I developed a heart issue: Erratic heartbeat began after dose 1 in Mar2021; Fuzzy head and foggy thinking; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Mar2021 (Lot number: ER8730) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "known allergies: Yellow #6" (unspecified if ongoing), notes: known allergies: NSAIDS, yellow #6. Concomitant medication(s) included: SYNTHROID. Past drug history included: Nsaids, reaction(s): "known allergies: NSAIDS", notes: known allergies: NSAIDS, yellow #6. The following information was reported: ILLNESS (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Extremely ill"; PYREXIA (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Fever"; FATIGUE (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Extreme fatigue"; PAIN (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Pain"; MYALGIA (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Muscle aches"; HEADACHE (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Headache"; FEELING ABNORMAL (non-serious), THINKING ABNORMAL (non-serious) all with onset Mar2021, outcome "recovered" (2021) and all described as "Fuzzy head and foggy thinking"; FEELING ABNORMAL (non-serious) with onset Mar2021, outcome "recovered", described as "feeling absolutely miserable beginning 24 hours after 1st dose"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset Mar2021, outcome "recovered" (2021), described as "Could not work"; HEART RATE IRREGULAR (non-serious) with onset Mar2021, outcome "recovered" (Oct2021), described as "I developed a heart issue: Erratic heartbeat began after dose 1 in Mar2021". The events "extremely ill", "fever", "extreme fatigue", "pain", "muscle aches", "headache", "fuzzy head and foggy thinking", "feeling absolutely miserable beginning 24 hours after 1st dose", "could not work", "i developed a heart issue: erratic heartbeat began after dose 1 in mar2021" and "fuzzy head and foggy thinking" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of illness, pyrexia, fatigue, pain, myalgia, headache, feeling abnormal, feeling abnormal, loss of personal independence in daily activities, heart rate irregular, thinking abnormal.  Additional information: Patient has not taken any other vaccines in 4 weeks and patient has no COVID prior to vaccination and patient has no other medical history. device timestamp: 14Jan2022.  No follow-up attempts are possible. No further information is expected.
he is just not feeling well at all; His blood pressure is 150/110; This is a spontaneous report from a contactable consumer. This consumer reported  for patient(fiance) that:  A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced he is just not feeling well at all, his blood pressure is 150/110. The patient underwent lab tests and procedures which included blood pressure: 150/110 on unspecified date. Event occurred in a country different from that of the reporter. The clinical outcome of events were unknown.  QR Comment: Reporter type could not be probed hence captured by default as Consumer or other non-health professional in tab.  Information on the lot/batch number has been requested.
Recurring sore throat that comes and goes; after second dose and still ongoing; Chills; Spike of fever/may be a slight fever; Aching around the joints; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Recurring sore throat that comes and goes; after second dose and still ongoing), CHILLS (Chills), PYREXIA (Spike of fever/may be a slight fever), ARTHRALGIA (Aching around the joints) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Spike of fever/may be a slight fever), ARTHRALGIA (Aching around the joints) and FATIGUE (Fatigue). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Recurring sore throat that comes and goes; after second dose and still ongoing). On 22-Feb-2021, CHILLS (Chills), PYREXIA (Spike of fever/may be a slight fever), ARTHRALGIA (Aching around the joints) and FATIGUE (Fatigue) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Recurring sore throat that comes and goes; after second dose and still ongoing) had not resolved.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-017860 (Patient Link).
c/o body pain, nausea, vomiting, unable to tolerate fluids; Adverse rxn to Heptavax;
they felt strange; headache; muscles pains on their legs and thighs; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (they felt strange), HEADACHE (headache) and MYALGIA (muscles pains on their legs and thighs) in an 80-year-old patient of an unknown gender who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     The patient's past medical history included Surgery (Heart Procedure).   On 12-Oct-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) at an unspecified dose. On 13-Oct-2023, the patient experienced HEADACHE (headache) and MYALGIA (muscles pains on their legs and thighs). On an unknown date, the patient experienced FEELING ABNORMAL (they felt strange). The patient was treated with PARACETAMOL (TYLENOL) in October 2023 for Headache, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (they felt strange) outcome was unknown and HEADACHE (headache) and MYALGIA (muscles pains on their legs and thighs) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.   Reporter did not allow further contact
No period for 42 days (after expected period missed 3 days after shot). Night sweats every 4 hours for 24 days after shot.
11/20/2021 Wheezing on Saturday, was constant by that Tuesday (10/23/2021) and was constantly coughing and cough syrup and rescue inhaler was not helping much. It was very hard to breath correctly and couldn't converse much. Went to Urgent care but they did not have the facilities for my asthma. Referred to ER. After observation and confirming 3 prior COVID-19 test (negative) Oral corticosteroid administered Dexamethasone was issued a new inhaler and was told to resume my Q bar for treatment.
This spontaneous report as received from a Physician Assistant refers to a 3 week old patient of unknown gender. On an unknown date the patient was vaccinated with HepA vaccine (manufacturer unknown) (dose, route, lot number and expiration date not reported). There was no concomitant medication reported. The physician assistant stated that an unspecified Physician Medical Assistant had accidentally administered an unspecified HepA vaccine to a 3 weeks old patient on an unspecified date. No adverse effect was reported. Additional information has been requested.
No additional adverse event; dose of PROQU AD that was administered improperly stored; This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication.  On an unspecified date in 2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) at a dose of 0.5 milliliter, lot number T027115 and expiration date of 07-FEB-2022 for prophylaxis (route of administration and anatomical location were unknown).   The vaccine was exposed to a temperature excursion 6°F to 14°F (8.5°F) for 0 hours 18 minutes and 0 seconds; 6°F to 14°F (11.9°F) for 1 hour 0 minutes and 0 seconds with a time frame of 45 minutes (Cumulative Timeframe: 1 hour and 18 minutes). There was no previous temperature excursion. No additional adverse events were reported.
pt recvd vax & exp severe constitutional sxs-N/fever, chills & arm swelling; reported @ pt's request
After receiving MENACTRA, ADACEL, flu and GARDASIL, pt fell to the ground and had a brief Sz with stiffening lasting 30-60 secs.
pt has been more sleepy past 4 days; hypotensive in ED; found to be positive for COVID; started on ABX; O2 supplementation; acute encephalopathy and dehydration; pt coded the day after admission and was pronounced deceased in the hospital
Patient states arm was sore immediately after getting the flu shot and has remained that way ever since.  She states it feels bruised and applying pressure to the area hurts.  Today she woke to it feeling numb but is unsure if that is related to her previous neck problems.
Minor pain; Lymph node swelling (left); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Minor pain) and LYMPHADENOPATHY (Lymph node swelling (left)) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal).    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced LYMPHADENOPATHY (Lymph node swelling (left)). On 15-Mar-2021, the patient experienced PAIN (Minor pain). At the time of the report, PAIN (Minor pain) and LYMPHADENOPATHY (Lymph node swelling (left)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Mammogram: inconclusive (Inconclusive) had annual mammogram and radiologist recommended the she receive the second Moderna vaccine in the opposite arm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Pt received TRUMENBA in right deltoid on 04/03/19. The next morning, patient's mother called the clinic and reported that the previous night pt's shoulder was red, "splotchy", and hot extending slightly onto his shoulder. She gave him BENADRYL, MOTRIN, and used cold pack to area and symptoms lessened. The next morning area had improved greatly. When area assessed in clinic approx. 24 hours after injection, there was a red area that was warm to the touch approximately the size of a golf ball. Pt denied trouble breathing, itchy throat, or throat swelling at any time.
Pt presented with hives, urticaria, joint pain, swelling, low-grade fever and headache.
48 hours of pain in arm. Flu-like malaise for 36 hours (without fever).